News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

UCB Group (UCBJF.PK) Release: New Post-Hoc Analyses Examined Neupro® Effects on Pain, Depressed Mood, Apathy and Fatigue in Patients with Parkinson’s Disease



4/26/2012 10:57:55 AM

ATLANTA--(BUSINESS WIRE)--Insights into the effects of Neupro® (rotigotine transdermal system) on common non-motor symptoms of Parkinson’s disease (PD) were presented today at the 64th AAN Annual Meeting in New Orleans, LA.

Read at BioSpace.com

Related News

comments powered by Disqus
UCB Group
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES